Eikon Therapeutics · 9 hours ago
Manager, Statistical Programming
Jersey City, NJ
Full-time
Hybrid
Mid, Senior Level
$143K/yr - $157K/yr
4+ years expEikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. The Manager, Statistical Programming will be responsible for statistical analysis and programming activities, ensuring the integrity and accuracy of data-driven insights that drive research and development efforts.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Statistical Analysis: Collaborate with cross-functional teams to design, develop, and implement statistical analyses and programming solutions for research studies, clinical trials, and experimental data
Data Integrity: Ensure the quality and integrity of data by implementing rigorous data review processes and adherence to industry standards and regulatory requirements
Programming: Oversee and review programming activities, including the creation and validation of analysis datasets, tables, listings, and figures for regulatory submissions and internal decision-making
Process Improvement: Continuously improve and streamline statistical programming processes, methodologies, and standard operating procedures to enhance efficiency and productivity
Quality Assurance: Perform quality control and validation checks to maintain the accuracy and consistency of statistical outputs
Collaboration: Collaborate with cross-functional teams, including biostatistics, clinical operations, data management, and research teams, to ensure alignment and timely delivery of statistical programming deliverables
Training and Development: Provide training, guidance, and support to team members, fostering their professional growth and development
Compliance: Ensure compliance with industry standards, regulatory guidelines, and company policies related to statistical programming activities
Qualification
Required
Post Graduate degree with 4+ years of experience or a Bachelor's degree with 6+ years of experience in a relevant field (e.g., statistics, biostatistics, computer science, or a related discipline)
Significant experience in statistical programming within the biotechnology, pharmaceutical, or healthcare industry
Proficiency in programming languages commonly used in statistical analysis (e.g., SAS, R, Python)
SQL programming experience required
Strong leadership and team management skills
Excellent communication and interpersonal skills, with the ability to collaborate effectively with cross-functional teams
Knowledge of regulatory guidelines (e.g., FDA, EMA) and industry standards for statistical programming
Demonstrated problem-solving abilities and attention to detail
Ability to adapt to a fast-paced and dynamic work environment
Commitment to maintaining the highest standards of data quality and integrity
Preferred
AI or automation experience is a plus
Benefits
401k plan with company matching
Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)
Mental health and wellness benefits
Weeklong summer and winter holiday shutdowns
Generous paid time off and holiday policies
Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies
Enhanced parental leave benefit
Daily subsidized lunch program when on-site
Company
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
201-500 employees
H1B Sponsorship
Eikon Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (17)
2023 (7)
2022 (3)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$1.12BKey Investors
The Column Group
2025-02-26Series D· $350.7M
2023-06-01Series C· $106M
2022-01-06Series B· $518M
Leadership Team
Roger Perlmutter
Chairman, President, and CEO
Michael Klobuchar
Chief Operating Officer
Recent News
2026-01-19
pharmaphorum
2026-01-14
Company data provided by crunchbase